Neovii

Neovii focuses on polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology/oncology.

Biotechnology

Explore the company ↓Explore its lists ↓

Headquarters: Rapperswil, Sankt Gallen, SwitzerlandSource: RevenueBaseRetrieved October 13, 2026
Employee range: 51 to 200Source: RevenueBaseRetrieved October 13, 2026
Founded: 2003Source: RevenueBaseRetrieved October 13, 2026
Published list appearances: 6 supported appearances ↗Source: RevenueBase lists

The company at a glance

What does Neovii do?

Neovii’s lead product is Grafalon®, which the source says has been used for over 30 years and is available in more than 40 countries. The source states that Grafalon® is approved for immunosuppressive therapy to prevent graft-versus-host disease in stem cell transplantation, prevent and treat rejection in solid organ transplantation, and treat aplastic anemia.

Based on the company’s public LinkedIn information, supplied through RevenueBase.

Explore the business in context

Snapshot: September 19, 2026

↗

Positions describe ordering within each source list. See how lists are built ↗

Share your recognition

Embeddable award for your website

BADGE PREVIEW

Open the published source list.

Neovii

#1 Immunotherapy centers

Snapshot: September 19, 2026

Display size

Download SVG

Copy this code into your website

<a href="https://revenuebase.ai/companies/immunotherapy-centers/switzerland" target="_blank" rel="nofollow noopener">
  <img src="https://revenuebase.ai/companies/profiles/neovii/recognition-companies-immunotherapy-centers-switzerland-20260920-2fa21c81dfb4e42213d93063c5a0b0a88a704bace29e30abf7bc51c2713178b5.svg" alt="Neovii listed #1 on Immunotherapy centers, September 19, 2026" width="220" height="319" style="max-width:100%;height:auto;" />
</a>

View live list ↗

Sources & data notes.

RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 15, 2026 and September 19, 2026. How the company lists are built.

Help keep this profile accurate

Something changed?

Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.

Request an update ↗

Find your next account

One company is just the start.

Explore more companies by name, headquarters and business focus.

Explore company profiles →